Lv11
26 积分 2021-07-19 加入
VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes
45分钟前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
27天前
已完结
免疫检查点失调及其在免疫检查点抑制剂相关肺炎中的机制研究进展
28天前
已完结
Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers
28天前
已完结
免疫检查点抑制剂相关肺炎诊治和管理专家共识(2025)
28天前
已完结
Izalontamab brengitecan (Iza-bren; BL-B01D1), a first-in-class EGFR HER3 bispecific antibody–drug conjugate, for patients with EGFR mutated NSCLC: pooled analysis of phase I and phase II trials
28天前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
28天前
已完结
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
1个月前
已完结
皖公网安备34019202002308
